Weight-loss jabs to be offered on NHS for people at risk of further heart attacks

Importantly, NICE (National Institute for Health and Care Excellence) says the benefits were seen early in the clinical trial before significant weight loss occurred, suggesting that the drug works directly on the heart and blood vessels and not just through weight loss.